Samuel Hopkins
Keine laufenden Positionen mehr
Profil
Samuel Hopkins worked as the Chief Scientific Officer at SCYNEXIS, Inc. and as the President of Research & Development at Parion Sciences, Inc. Prior to that, he was the Senior Vice President of Medical Affairs at Trimeris, Inc. Hopkins received his doctorate from the Medical College of Virginia in 1985 and his undergraduate degree from Western University of Health Sciences in 1980.
Ehemalige bekannte Positionen von Samuel Hopkins
| Unternehmen | Position | Ende |
|---|---|---|
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
Parion Sciences, Inc.
 Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| SCYNEXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Samuel Hopkins
| Western University of Health Sciences | Undergraduate Degree |
| Medical College of Virginia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCYNEXIS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Parion Sciences, Inc.
Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Commercial Services |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
